Dhampur Bio Organics Limited has informed the Exchange about Transcript
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics posted FY25 revenue of ₹2,714.40 crores, up 14.96% YoY, but PAT fell sharply to ₹12 crores from ₹49 crores due to lower ethanol volumes and sugar recovery issues. Q4 FY25 was relatively stronger with revenue of ₹702 crores and PAT of ₹40 crores. The Sugar segment did well (EBIT up to ₹109 crores from ₹79 crores) and Country Liquor surged 55% to ₹925 crores, but the Biofuels/ethanol segment saw EBIT collapse from ₹56 crores to ₹11 crores on lower production and unrevised ethanol prices. Sugar production dropped to 3.1 lakh MT and net recovery slipped to 9.8% from 10.32% due to red rot disease and pest issues. The Board declared a dividend of ₹1.25 per share. Management indicated no major capex plans and expects debt to come down substantially.
Mixed results with headline PAT hit hard by ethanol segment weakness despite strong top-line growth, but Country Liquor remains a bright spot with 30-40% growth targeted. Stock may react cautiously given margin pressure in ethanol and lower sugar production, though dividend announcement and debt reduction outlook provide some support.